Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Odirichukwu O. Duru"'
Autor:
Kristina Roddy, Odirichukwu O. Duru, Gregory M. Novak, Monique R Bidell, J. Nicholas O'Donnell, Benjamin R. Bratek, Gurkirat Singh, Colby Mitchell
Publikováno v:
International journal of antimicrobial agents. 57(4)
Clostridioides difficile infection (CDI) is a significant cause of morbidity and mortality. Oral vancomycin is a cornerstone of CDI treatment, but dosing strategies in clinical practice may differ from guideline recommendations. This study aimed to d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8df36554b6fc5370777f06e4038fcee
https://pubmed.ncbi.nlm.nih.gov/33621602
https://pubmed.ncbi.nlm.nih.gov/33621602
Autor:
Benjamin Bratek, J. Nicholas O'Donnell, Colby Mitchell, Gurkirat Singh, Odirichukwu O. Duru, Monique Bidell, Gregory Novak
Publikováno v:
Open Forum Infectious Diseases
Background Clostridium difficile infection (CDI) is a significant cause of morbidity and mortality. IDSA guidelines recommend oral vancomycin (VAN) for the treatment of CDI, although doses used in practice vary substantially. The purpose of this stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d63e234913fc1d2d79409f069ac276ea
http://europepmc.org/articles/PMC6254310
http://europepmc.org/articles/PMC6254310